About MEDRAD
MEDRAD, INC. develops, markets and services medical devices used to diagnose and treat disease. Its product offerings include fluid injection systems for radiology and cardiology, endovascular devices for the safe treatment of cardiovascular disease, magnetic resonance-compatible accessories and equipment services. MEDRAD’s total 2008 revenues were over $600 million. The company’s world headquarters is near Pittsburgh, Pennsylvania, in the United States. MEDRAD is a business of Bayer Medical Care.
MEDRAD Details
Company Name
MEDRAD, INC.Address
100 Global View Drive, Warrendale, PA 15086, USAHeadquarters City
WarrendaleCountry of Incorporation
USAProduct Areas
MEDRAD News
- MEDRAD® Announces Launch of VirtualCARE® Remote Services Solution for Intego™ PET Infusion System
- MEDRAD Honored for a Second Time With Prestigious Malcolm Baldrige National Quality Award
- Personalized Protocol Contrast-Dosing Software Increases Diagnostic Quality CT Pulmonary Angiography Studies(1)
- MEDRAD Employees Demonstrate Longstanding Commitment to Community
- MEDRAD Intego Cleared by FDA as First System for Automated F18- Sodium Fluoride Infusion used in PET Bone Cancer Imaging
- MEDRAD MVS Announces Ultrasound Probe Repair Facility
- MEDRAD - B. Braun: Co-marketing & Trademark License Agreement
- MEDRAD's PACS Injection-Record Integration; RSNA
- MEDRAD Partners with the University of South Florida and Moffitt Cancer Center
- MEDRAD Recognized by the Premier Healthcare Alliance for Commitment to Healthcare Quality Improvement and Innovation
2120
